The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: "ehsl_novel_nam"
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 776 |
 |
Appearance and Disappearance of Callosal Lesions in Susac Syndrome | Robert A. Egan, David Clark | NAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology |
| 777 |
 |
Appearance of cavernous angiomas after brain radiation therapy | Yanny Phillips; Eric Eggenberger | NANOS 2012: Poster Presentations |
| 778 |
 |
The Application of OCTA in Optic Neuropathy (video) | Marie-Benedicte Rougier | NANOS Annual Meeting 2017: Applications of Advanced Retinal Vascular Imaging in Neuro-Ophthalmology |
| 779 |
 |
Applying laboratory data in temporal artery biopsy decisions | Lindsey B. De Lott; Marie Acierno; Adeela Alizai; Dennis Anderson; Schlomo Dotan; David Katz; Edward Margolin; Iris Mizrachi; Padmaja Sudhakar; Wayne Cornblath; Jonathan Trobe | NANOS 2014: Poster Presentations |
| 780 |
 |
Applying Neural Networks to Macular OCTA to Differentiate LHON Vasculature from Normal Vasculature | William Sultan; Giulia Amore; Kashif Iqbal; Samuel Asanad; Rustum Karanji; Alfredo Sadun | NANOS Annual Meeting 2021: Poster Session III: New Diagnostic Measurement Techniques |
| 781 |
 |
Apraclonidine - An Eye Opener! | Fabienne Fierz; Leah Disse; Christopher Bockisch; Konrad Weber | NANOS Annual Meeting 2022: Poster Session I: New Diagnostic Measurement Techniques |
| 782 |
 |
Apraclonidine 0,5 % in the Treatment of the Ptosis in the Horner Syndrome | Bernardo F. Sanchez-Dalmau; Barbara Romero; Jorge Arruga; M. D. Vela Payan; A. Adan Civera | NANOS 2006: Poster Presentations |
| 783 |
 |
Apraxia of Eyelid Opening: A Cause or Botulinum Failure | Steven A. Newman; Michael L. Slavin; Larry Phillips | NANOS 1988: Scientific Platform Presentations (Session 2) |
| 784 |
 |
Aquaporin 4 Antibody in the Korean Patient with Newly Onset Optic Neuritis (.pdf) | Ungsoo Samuel Kim; Kyung Min Kim; Seung-Hee Paik | NANOS Annual Meeting 2016: Poster Presentations |
| 785 |
 |
Aquaporin-4 Antibody-Positive Optic Neuritis In Thai Patients | Pisit Preechawat; Supanut Apinyawasisuk; Panitha Jindahra; Anuchit Poonyathalang; Metha Apiwattanakul | NANOS 2014: Poster Presentations |
| 786 |
 |
Aquaporumab: An Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica | Jeffrey Bennett; Lukmanee Tradtrantip; Hua Zhang; Samira Saadoun; Puay-Wah Phuan; Chiwah Lam; Marios Papadopoulos; Alan Verkman | NANOS 2012: Scientific Platform Presentations (Session I) |
| 787 |
 |
Arachnoid Granulations and Cerebrospinal Fluid Flow: An In-Vitro Model for Blood-Brain Barrier | Deborah M. Grzybowski, PhD; David W. Holman, BS; Steven E. Katz, MD; Martin Lubow, MD | |
| 788 |
 |
Archetypal Analysis Identifies Quantifiable Visual Field Loss Patterns and Predictors of Recovery in Optic Neuritis | Elena Solli; Hiten Doshi; Tobias Elze; Louis Pasquale; Michael Wall; Mark Kupersmith | NANOS Annual Meeting 2021: Journal Club: What You Need to Know Now! |
| 789 |
 |
Archetypal Analysis Identifies Quantifiable Visual Field Loss Patterns and Predictors of Recovery in Optic Neuritis | Elena Solli; Hiten Doshi; Tobias Elze; Louis Pasquale; Michael Wall; Mark Kupersmith | NANOS Annual Meeting 2021: Journal Club: What You Need to Know Now! |
| 790 |
 |
Archetypal Analysis Identifies Quantifiable Visual Field Loss Patterns and Predictors of Recovery in Optic Neuritis | Elena Solli; Hiten Doshi; Tobias Elze; Louis Pasquale; Michael Wall; Mark Kupersmith | NANOS Annual Meeting 2021: Journal Club: What You Need to Know Now! |
| 791 |
 |
The Architecture of the Arachnoid Trabeculae and Septae in the Subarachnoid Space of the Human Optic Nerve: Anatomy and Clinical Considerations | H. E. Killer, MD; Hubert R. Laeng; Josef Flammer; Peter Groscurth | NANOS 2002: Poster Presentations |
| 792 |
 |
Are Eye Symptoms a Trigger of Blepharospasm? | Katie Luneau; Michele Mabon; Dan Boghen | NANOS 2007: Poster Presentations |
| 793 |
 |
Are Koniocellular Pathways Involved in Visual Snow Pathophysiology? | Jenny Hepschke; Paul Martin; Clare Fraser | NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements |
| 794 |
 |
Are MRI Findings Sufficient to Allow a Diagnosis of Idiopathic Intracranial Hypertension without CSF Study? | Homer Chiang; John Carter; Bundhit Tantiwongkosi | NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights |
| 795 |
 |
Are MRI Findings Sufficient to Allow a Diagnosis of Idiopathic Intracranial Hypertension Without CSF Study? | Homer Chiang; John Carter; Bundhit Tantiwongkosi | NANOS Annual Meeting 2021: Poster Session IV: Idiopathic Intracranial Hypertension (IIH) |
| 796 |
 |
Are patients with thyroid orbitopathy deficient in selenium and/or vitamin D? | Ama Sadaka; Shauna Berry | NANOS 2017: Poster Presentations |
| 797 |
 |
Are Prosopagnosic Patients Truly Prosopagnosic? Selectivity for Visual Object Type and Sensory Modality in Acquired Deficits of Face Recognition | Jason J. S. Barton; Richard Liu; Raika Pançaroglu; Charlotte Hills; Brad Duchaine | NANOS 2014: Poster Presentations |
| 798 |
 |
Are Red-Green Color Tests the Best Option Out There? | Naomie Kraus; Nilufer Kale; Eric Eggenberger | NANOS 2010: Poster Presentations |
| 799 |
 |
Are Sunglasses Predictive of Non-Organic Visual Loss (NOVL) in Neuroophthalmologic Practice? | Rachel Bengtzen, Maria Woodward, Michael Lynn, Nancy Newman, Valerie Biousse | NANOS 2007: Poster Presentations |
| 800 |
 |
Are the 2016 Guidelines on the Neuro-ophthalmic Evaluation of Pituitary Adenomas Already Obsolete? | Jonathan Micieli; Richard Blanch; Eman Hawy; Jason Peragallo; Kannan Narayana; Nancy Newman; Valerie Biousse | NANOS 2018: Poster Presentations |